QT Prolongation and In-Hospital Ventricular Arrhythmic Complications in Patients With Apical Ballooning Takotsubo Syndrome

Medina de Chazal, 2018, Stress cardiomyopathy diagnosis and treatment: JACC state-of-the-art review, J Am Coll Cardiol, 72, 1955, 10.1016/j.jacc.2018.07.072 Templin, 2019, Altered limbic and autonomic processing supports brain-heart axis in Takotsubo syndrome, Eur Heart J, 40, 1183, 10.1093/eurheartj/ehz068 Sonnino, 2017, Lack of soluble circulating cardiodepressant factors in Takotsubo cardiomyopathy, Auton Neurosci, 208, 170, 10.1016/j.autneu.2017.10.010 Montone, 2020, Special Article - Emotional versus physical Takotsubo syndrome: Two faces of the same medal or two different syndromes?, Prog Cardiovasc Dis, 63, 699, 10.1016/j.pcad.2020.07.005 Montone, 2020, Coronary slow flow is associated with a worse clinical outcome in patients with Takotsubo syndrome, Heart, 106, 923, 10.1136/heartjnl-2019-315909 Del Buono, 2021, Left ventricular end-diastolic pressure predicts in-hospital outcomes in Takotsubo syndrome, Eur Heart J Acute Cardiovasc Care, 10, 661, 10.1093/ehjacc/zuab028 Del Buono, 2017, Cardiac arrest due to ventricular fibrillation in a 23-year-old woman with broken heart syndrome, Cardiovasc Pathol, 30, 78, 10.1016/j.carpath.2017.06.007 Stiermaier, 2015, Prevalence and clinical significance of life-threatening arrhythmias in Takotsubo cardiomyopathy, J Am Coll Cardiol, 65, 2148, 10.1016/j.jacc.2015.02.062 Watson, 2019, Comparing the variants of Takotsubo syndrome: An observational study of the ECG and structural changes from a New Zealand tertiary hospital, BMJ Open, 9, 10.1136/bmjopen-2018-025253 Santoro, 2017, Dynamic changes of QTc interval and prognostic significance in Takotsubo (stress) cardiomyopathy, Clin Cardiol, 40, 1116, 10.1002/clc.22798 Pelargonio, 2021, Ventricular arrhythmias in Takotsubo syndrome: Incidence, predictors and clinical outcomes, J Cardiovasc Med (Hagerstown), 22, 180, 10.2459/JCM.0000000000001106 Ravindra, 2021, Clinical features and outcomes between African American and Caucasian patients with Takotsubo syndrome, Minerva Cardiol Angiol, 69, 750, 10.23736/S2724-5683.20.05456-0 Vink, 2018, Determination and interpretation of the QT interval, Circulation, 138, 2345, 10.1161/CIRCULATIONAHA.118.033943 Montone RA, La Vecchia G, Del Buono MG, et al. Takotsubo syndrome in intensive cardiac care unit: Challenges in diagnosis and management. Curr Problem Cardiol. 2022;47(11):101084. https://doi.org/10.1016/j.cpcardiol.2021.101084 Pant, 2013, Burden of arrhythmias in patients with Takotsubo cardiomyopathy (apical ballooning syndrome), Int J Cardiol, 170, 64, 10.1016/j.ijcard.2013.10.041 Madias, 2011, Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes, Heart Rhythm, 8, 555, 10.1016/j.hrthm.2010.12.012 Gili, 2019, Cardiac arrest in Takotsubo syndrome: Results from the InterTAK registry, Eur Heart J, 40, 2142, 10.1093/eurheartj/ehz170 McLaren, 2005, Autonomic function is impaired in elderly stroke survivors, Stroke, 36, 1026, 10.1161/01.STR.0000160748.88374.ce Imran, 2016, QT prolongation and clinical outcomes in patients with Takotsubo cardiomyopathy. pacing, Clin Electrophysiol, 39, 607, 10.1111/pace.12864 Roden, 2006, Long QT syndrome: Reduced repolarization reserve and the genetic link, J Intern Med, 259, 59, 10.1111/j.1365-2796.2005.01589.x Behr, 2009, Takotsubo cardiomyopathy and the long-QT syndrome: An insult to repolarization reserve, Europace, 11, 697, 10.1093/europace/eup081 Song, 2014, The QT prolongation and clinical features in patients with Takotsubo cardiomyopathy: Experiences of two tertiary cardiovascular centers, Anadolu Kardiyol Derg, 14, 162, 10.5152/akd.2013.4745 U.S. Food and Drug Administration. Guidance Document: E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. October 2012. Guidance for industry E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic-drugs. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e14-clinical-evaluation-qtqtc-interval-prolongation-and-proarrhythmic-potential-non-antiarrhythmic-0 Accessed May 20, 2022. Andršová, 2021, Influence of heart rate correction formulas on QTc interval stability, Sci Rep, 11, 10.1038/s41598-021-93774-9 Dusi, 2019, Cardiopulmonary performance after left cardiac sympathetic denervation for long QT syndromes: Yes we can, J Am Coll Cardiol EP, 5, 1091 Cardona-Guarache, 2017, Stellate ganglion blockade and bilateral cardiac sympathetic denervation in patients with life-threatening ventricular arrhythmias, J Cardiovasc Electrophysiol, 28, 903, 10.1111/jce.13249 Savastano, 2021, Anatomical-based percutaneous left stellate ganglion block in patients with drug-refractory electrical storm and structural heart disease: A single-centre case series, Europace, 23, 581, 10.1093/europace/euaa319 Ghadri, 2018, Long-term prognosis of patients with Takotsubo syndrome, J Am Coll Cardiol, 72, 874, 10.1016/j.jacc.2018.06.016 Lu, 2021, Prognostic factors of Takotsubo cardiomyopathy: A systematic review, ESC Heart Fail, 8, 3663, 10.1002/ehf2.13531 Cammann, 2021, Clinical correlates and prognostic impact of neurologic disorders in Takotsubo syndrome, Sci Rep, 11, 10.1038/s41598-021-01496-9 Uribarri, 2019, Short- and long-term prognosis of patients with Takotsubo syndrome based on different triggers: Importance of the physical nature, J Am Heart Assoc, 8